Shirali Suryakant Patel, MD

Shirali Suryakant Patel, MD, is a board-certified psychiatrist at Kelsey-Seybold. She earned her medical degree at Baylor College of Medicine in Houston, Texas, in 2012. She remained there to complete her General Psychiatry Residency in 2017. Dr. Patel joined Kelsey-Seybold’s Behavioral Health department in September 2024.

Guided toward psychiatry by a mentor in college, Dr. Patel treats individuals struggling with their mental health. This includes a variety of conditions, including adjustment disorders, depression and anxiety disorders, PTSD, and other psychiatric disorders. She has a particular interest in helping patients with depression and anxiety disorders, as well as identity and work/relationship struggles. Her favorite part of practicing medicine is building lasting relationships with patients.

Awards & Publications

Awards

• Laughlin Family Foundation Outstanding Psychiatric Resident Award, Baylor College of Medicine, 2017
• Stacia Micheletto Award, Baylor College of Medicine Annual award given to one resident for excellence in psychiatry/psychotherapy, 2016
• Gold Humanism Honor Society Inductee, Baylor College of Medicine, 2016
• Baylor Psychiatry Clinic Productivity Award, Baylor College of Medicine, 2015
• Albert Schweitzer Fellow for Houston-Galveston Program, 2011

Publications

Patel, S., Brenner, A. Fitting the Therapy and the Therapist to the Patient, chapter contributor. Psychotherapy: A Practical Introduction. ed. Adam Brenner and Laura S. Howe-Martin. LWW; 1st edition (December 31, 2020).

Patel, S., Brenner, A. Case Based Application of the Differential Psychotherapeutics Cycle, chapter contributor. Different Patients, Different Therapies: Optimizing Treatment Using Differential Psychotherapeutics, ed. Deborah Cabaniss and Yael Holoshitz. W. W. Norton & Company; 1st edition (October 8, 2019)

Research

Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) sub-investigator (2019 — 2022)

Safety and Sustenance of Esketamine Treatment Response with Repeated Doses at Intervals Determined by Symptom Severity (SUSTAIN-3), Janssen Research and Development, sub-investigator (2018 — 2019)

Augmentation versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Nonresponders with Treatment Resistant Depression (ASCERTAIN-TRD), Patient-Centered Outcomes Research Institute (PCORI), sub-investigator (2018 — 2021)

Hobbies & Interests